Related content

The Effectiveness of S-1 Based Sequential Chemotherapy as Second-Line Treatment for Advanced/Recurrent Gastric Cancer

By Sugimoto Naotoshi   Narahara Hiroyuki   Sakai Daisuke   Yamamoto Sachiko   Fumoto Shoichi   Yagi Toshinari   Imamura Fumio   Iishi Hiroyasu   Tatsuta Masaharu  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 417-424

Sunmedia

Access to resources Recommend Favorite

Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer

By Kochi Mitsugu   Fujii Masashi   Kanamori Noriaki   Kaiga Teruo   Takahashi Toru   Kobayashi Michiyo   Takayama Tadatoshi  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 12, 2006-12 ,pp. : 781-785

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer

By Kusaba Hitoshi   Esaki Taito   Kishimoto Junji   Uchino Keita   Arita Shuji   Kumagai Hozumi   Mitsugi Kenji   Akashi Koichi   Baba Eishi  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 29-34

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer

By                          

Oncology Letters, Vol. 2, Iss. 6, 2011-01 ,pp. : 1253-1256

Spandidos Publications

Access to resources Recommend Favorite

Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer

By Takahari Daisuke   Shimada Yasuhiro   Takeshita Shigeyuki   Nishitani Hitoshi   Takashima Atsuo   Okita Natsuko   Hirashima Yoshinori   Kato Ken   Hamaguchi Tetsuya   Yamada Yasuhide   Shirao Kuniaki  

Gastric Cancer, Vol. 13, Iss. 3, 2010-08 ,pp. : 186-190

Springer Publishing Company

Access to resources Recommend Favorite